《高盛认股证牛熊证》医疗科技股走势各异 留意高杠杆京健购24921、里康远牛65272
医疗科技股今早走势各异，京东健康(6618)获券商首次给予买入评级，股价急升逾6%，现报105元，从周初的低位明显反弹。反观阿里健康(0241)则持续疲弱，股价今早低见17.62元的今年低位，现仍下跌近4%，报17.84元，是现时跌幅最大的蓝筹股。另外，平医(1833)亦上升0.6%，报90.35元
观察轮证资金流向，过去5个交易日资金持续流入京东健康认购证，合共流入近400万元，看好可留意京健购24921，属价外、高杠杆产品，是市场最高杠杆的认购证之一。
京健购24921，行使价151.38元，2021年11月8日到期，实际杠杆6.3倍，市场最高杠杆的认购证之一
阿里健康股价落後吸引资金留意其牛证，而且开始转仓至收回价较远的产品，远牛可留意里康牛65272，是低街货的选择；高杠杆、贴价牛则可留意里康牛66960，适合作短线部署。
里康牛65272，收回价16元，行使价15.4元，换股比率50，杠杆比率6.3倍，低街货远牛
里康牛66960，收回价17元，行使价16.4元，换股比率50，杠杆比率9.7倍，高杠杆、贴价牛
投资者如看好平医，认购证可留意平医购24239，是中期轻微价外证中杠杆最高，是条款及杠杆都突出的产品，值得留意；牛证则可留意贴价牛平医牛52850，是现时最贴价、最高杠杆的牛证之一。
平医购24239，行使价99.03元，2021年9月21日到期，实际杠杆7.8倍，行使价90至110元之间、2个月期以上产品中杠杆最高
平医牛52850，收回价80元，行使价76元，换股比率100，杠杆比率6倍，现时最贴价、最高杠杆的牛证之一
高盛医疗科技股精选：
京健购24921，行使价151.38元，2021年11月8日到期，实际杠杆6.3倍
里康牛65272，收回价16元，行使价15.4元，换股比率50，杠杆比率6.3倍
里康牛66960，收回价17元，行使价16.4元，换股比率50，杠杆比率9.7倍
平医购24239，行使价99.03元，2021年9月21日到期，实际杠杆7.8倍
平医牛52850，收回价80元，行使价76元，换股比率100，杠杆比率6倍
注: 以上数据资料来自高盛认股证牛熊证网站https://www.gswarrants.com.hk/~
重要声明:
以上资讯由第三方提供，AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告，不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料，本公司亦不负品质保证之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
